Literature DB >> 22937182

An interferon response gene expression signature is activated in a subset of medulloblastomas.

Eike Staub1.   

Abstract

Recent evidence suggests that cytomegalovirus infection contributes to the development of medulloblastomas. Differential activation of antiviral expression programs in medulloblastomas has not been investigated yet. In this study, we assess the relevance of an antiviral transcriptional response in medulloblastomas. We analyzed a gene expression signature of type I interferon response in three public gene expression data sets of medulloblastomas. Interferon response genes were found to be significantly coordinately regulated in two independent studies. We distilled a signature of 10 interferon response genes from two data sets. This signature exhibited strongly significant gene-versus-gene correlation of expression levels across samples in a third external medulloblastoma data set. Our medulloblastoma IFN signature identified a previously unrecognized patient subgroup partially overlapping the WNT and SHH subtypes proposed by others. We conclude that significant traces of differential activation of antiviral transcriptional response can be found in three independent medulloblastoma patient cohorts. This IFN activation signal often coincides with reduced proliferation scores. Our proposed 10-gene type I IFN response gene signature could help to assess antiviral states in further gene expression data sets of medulloblastomas or other cancers.

Entities:  

Year:  2012        PMID: 22937182      PMCID: PMC3431040          DOI: 10.1593/tlo.12214

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  27 in total

1.  Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.

Authors:  A Koch; A Waha; J C Tonn; N Sörensen; F Berthold; M Wolter; J Reifenberger; W Hartmann; W Friedl; G Reifenberger; O D Wiestler; T Pietsch
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

2.  Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.

Authors:  T Pietsch; A Waha; A Koch; J Kraus; S Albrecht; J Tonn; N Sörensen; F Berthold; B Henk; N Schmandt; H K Wolf; A von Deimling; B Wainwright; G Chenevix-Trench; O D Wiestler; C Wicking
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.

Authors:  Edward Pan; Malgorzata Pellarin; Emi Holmes; Ivan Smirnov; Anjan Misra; Charles G Eberhart; Peter C Burger; Jaclyn A Biegel; Burt G Feuerstein
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

4.  Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer.

Authors:  Uri Einav; Yuval Tabach; Gad Getz; Assif Yitzhaky; Ugur Ozbek; Ninette Amariglio; Shai Izraeli; Gideon Rechavi; Eytan Domany
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

5.  beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.

Authors:  David W Ellison; Olabisi E Onilude; Janet C Lindsey; Meryl E Lusher; Claire L Weston; Roger E Taylor; Andrew D Pearson; Steven C Clifford
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

6.  APC mutations in sporadic medulloblastomas.

Authors:  H Huang; B M Mahler-Araujo; A Sankila; L Chimelli; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.

Authors:  Naji Aldosari; Sandra H Bigner; Peter C Burger; Laurence Becker; James L Kepner; Henry S Friedman; Roger E McLendon
Journal:  Arch Pathol Lab Med       Date:  2002-05       Impact factor: 5.534

8.  Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.

Authors:  R P Dahmen; A Koch; D Denkhaus; J C Tonn; N Sörensen; F Berthold; J Behrens; W Birchmeier; O D Wiestler; T Pietsch
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

Review 9.  Pediatric brain tumors.

Authors:  A L Albright
Journal:  CA Cancer J Clin       Date:  1993 Sep-Oct       Impact factor: 508.702

10.  Mutations in SUFU predispose to medulloblastoma.

Authors:  Michael D Taylor; Ling Liu; Corey Raffel; Chi-chung Hui; Todd G Mainprize; Xiaoyun Zhang; Ron Agatep; Sharon Chiappa; Luzhang Gao; Anja Lowrance; Aihau Hao; Alisa M Goldstein; Theodora Stavrou; Stephen W Scherer; Wieslaw T Dura; Brandon Wainwright; Jeremy A Squire; James T Rutka; David Hogg
Journal:  Nat Genet       Date:  2002-06-17       Impact factor: 38.330

View more
  3 in total

1.  Characterization of human gene locus CYYR1: a complex multi-transcript system.

Authors:  Raffaella Casadei; Maria Chiara Pelleri; Lorenza Vitale; Federica Facchin; Silvia Canaider; Pierluigi Strippoli; Matteo Vian; Allison Piovesan; Eva Bianconi; Elisa Mariani; Francesco Piva; Flavia Frabetti
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

2.  Inhibition of ATM Increases Interferon Signaling and Sensitizes Pancreatic Cancer to Immune Checkpoint Blockade Therapy.

Authors:  Qiang Zhang; Michael D Green; Weiping Zou; Meredith A Morgan; Xueting Lang; Jenny Lazarus; Joshua D Parsels; Shuang Wei; Leslie A Parsels; Jiaqi Shi; Nithya Ramnath; Daniel R Wahl; Marina Pasca di Magliano; Timothy L Frankel; Ilona Kryczek; Yu L Lei; Theodore S Lawrence
Journal:  Cancer Res       Date:  2019-05-17       Impact factor: 12.701

3.  Conservation of immune gene signatures in solid tumors and prognostic implications.

Authors:  Julia Chifman; Ashok Pullikuth; Jeff W Chou; Davide Bedognetti; Lance D Miller
Journal:  BMC Cancer       Date:  2016-11-22       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.